Share Issue, PDMR Dealings & Total Voting Rights
EMV Capital plc has announced the issue of 200,141 new ordinary shares at £0.55 per share to directors and a PDMR to settle annual bonuses and fees, totaling £110,062.55. Additionally, directors Ed Hooper and Charles Spicer purchased 31,638 ordinary shares for £18,488.78. Following these transactions, the enlarged issued share capital will be 27,967,532 ordinary shares, with directors holding a combined 16.78% interest. Admission of the new shares is expected around December 12, 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your EMVC notes
Issue of Shares, Director/PDMR Dealings and Total Voting Rights
EMV Capital Plc (AIM: EMVC), the deep tech and life sciences VC investment group, announces the issue of 200,141 new ordinary shares of 5 pence each in the capital of the Company (Ordinary Shares) to certain of its directors and a PDMR in satisfaction of annual bonuses and fees (New Shares). The New Shares are being issued at a price of £0.55 per share. In addition, certain directors of the Company have purchased a total of 31,638 Ordinary Shares.
Issue of New Shares
Directors of the Company, Ilian Iliev, Ed Hooper, Jonathan Robinson and PDMR, Nick Salisbury, have agreed to receive New Shares (as detailed in the table below) in settlement of amounts owed to them by the Company rather than settlement in cash.
Such amounts owed are in the case of Ilian Iliev and Ed Hooper in respect of a proportion of the annual bonus awarded to them for the year ended 31 December 2024, in the case of Jonathan Robinson in respect of a proportion of outstanding fees and in the case of Nick Salisbury in respect of a proportion of a bonus payment for 2025. The New Shares are being issued at a price of £0.55 per share, being the average of the closing mid-market share price for the Ordinary Shares over the five dealing days prior to the date of this announcement.
| Director/PDMR | Number of New Shares issued | Total value |
|---|---|---|
| Ilian Iliev | 127,273 | £70,000.15 |
| Ed Hooper | 27,000 | £14,850.00 |
| Jonathan Robinson | 34,484 | £18,966.20 |
| Nick Salisbury | 11,384 | £6,261.20 |
Application will be made for the New Shares to be admitted to trading on AIM and it is expected that admission will take place on or around 12 December 2025 (Admission). The New Shares will rank pari passu in all respects with the Company's existing ordinary shares.
Purchase of Ordinary Shares
On 5 December 2025, the Company was notified that the following directors purchased Ordinary Shares through their Self Invested Personal Pensions, as detailed below (Director Dealings).
| Director | Number of Ordinary Shares acquired | Total price paid |
|---|---|---|
| Ed Hooper | 23,000 | £13,501.20 |
| Charles Spicer | 8,638 | £4,987.58 |
Directors Holdings
Following Admission and the Director Dealings, the Director's interests in the Ordinary Shares are as follows:
| Director | Total number of Ordinary Shares in which interested | % of Enlarged Issued Share Capital |
|---|---|---|
| Ilian Iliev | 4,013,246 | 14.35 |
| Ed Hooper | 380,000 | 1.36 |
| Jonathan Robinson | 233,737 | 0.84 |
| Charles Spicer | 64,924 | 0.23 |
| Total | 4,691,907 | 16.78 |
The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail on the issue of the Subscription Shares and the Director Dealings.
Total Voting Rights
Upon Admission, the issued share capital of the Company will consist of 27,967,532 Ordinary Shares (Enlarged Issued Share Capital). The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company from Admission will be 27,967,532. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Dr Ilian Iliev | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | Director | ||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||
| a) | Name | EMV Capital plc | ||||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||||
| b) | Nature of the transaction | Subscription for new Ordinary Shares | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||||
| e) | Date of the transaction | 5 December 2025 | ||||||
| f) | Place of the transaction | UK AIM | ||||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Ed Hooper | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | Director | ||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||
| a) | Name | EMV Capital plc | ||||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||||
| b) | Nature of the transaction | Subscription for new Ordinary Shares | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||||
| e) | Date of the transaction | 5 December 2025 | ||||||
| f) | Place of the transaction | UK AIM | ||||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Dr Jonathan Robinson | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | Director | ||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||
| a) | Name | EMV Capital plc | ||||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||||
| b) | Nature of the transaction | Subscription for new Ordinary Shares | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||||
| e) | Date of the transaction | 5 December 2025 | ||||||
| f) | Place of the transaction | UK AIM | ||||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Ed Hooper | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | Director | ||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||
| a) | Name | EMV Capital plc | ||||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||||
| b) | Nature of the transaction | Purchase of Ordinary Shares into SIPP | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information - Aggregated volume - Price | 23,000 £0.5870 | ||||||
| e) | Date of the transaction | 5 December 2025 | ||||||
| f) | Place of the transaction | UK AIM | ||||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Dr Charles Spicer | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | Director | ||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||
| a) | Name | EMV Capital plc | ||||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||||
| b) | Nature of the transaction | Purchase of Ordinary Shares into SIPP | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||||
| e) | Date of the transaction | 5 December 2025 | ||||||
| f) | Place of the transaction | UK AIM | ||||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Nick Salisbury | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | PDMR | ||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||
| a) | Name | EMV Capital plc | ||||||
| b) | LEI | 213800N5WD46G1Y7I458 | ||||||
| a) | Description of the financial instrument, type of instrument Identification code | EMVC 5p Ordinary Shares GB00BN4R5Q82 | ||||||
| b) | Nature of the transaction | Subscription for new Ordinary Shares | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information - Aggregated volume - Price | N/a | ||||||
| e) | Date of the transaction | 5 December 2025 | ||||||
| f) | Place of the transaction | UK AIM |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.